Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2019 | 2 |
2020 | 1 |
2021 | 1 |
2022 | 3 |
2024 | 1 |
Search Results
8 results
Results by year
The median OS was 100 months in patients who received melphalan 200 mg/m(2) compared to 41 months in the 140 mg/m(2) group (P < 0.0001). In conclusion, patients receiving novel therapy post ASCT and melphalan conditioning dosing at 200 mg/m(2) at diagnosis
…